Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system

V. Salucci, A. Scarito, L. Aurisicchio, S. Lamartina, G. Nicolaus, S. Giampaoli, O. Gonzalez-Paz, C. Toniatti, H. Bujard, W. Hillen, G. Ciliberto, F. Palombo

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Control of gene expression for gene therapy application requires the design of a sophisticated system embodying multiple properties. The ideal system should present the following features: (1) low or undetectable gene expression in the absence of inducer; (2) strong expression upon induction; and (3) fast kinetics of induction in the presence of inducers and rapid reversal of induction after its withdrawal. To evaluate these parameters, the features of the latest generation tetracycline-sensitive reverse-transactivator (rtTA2s-M2) alone or in combination with Tet-repressor (tTS-Kid) were explored in the context of helper-dependent adenovirus vector. Various genetic elements were assembled in a series of vectors and the ability to control secreted alkaline phosphatase expression evaluated in vitro in HeLa cells and in vivo by intramuscular injection in both C57/B6 and Balb/C nude mice. The results allow us to draw some general conclusions about the combination of transcription regulators and their relative orientation to the transgene to achieve maximal induction, while minimizing leakiness of expression.

Original languageEnglish
Pages (from-to)1415-1421
Number of pages7
JournalGene Therapy
Volume9
Issue number21
DOIs
Publication statusPublished - Nov 2002

Fingerprint

Trans-Activators
Tetracycline
Adenoviridae
Gene Expression
Intramuscular Injections
Transgenes
HeLa Cells
Nude Mice
Genetic Therapy
Alkaline Phosphatase
In Vitro Techniques

Keywords

  • Gene regulation
  • Helper-dependent adenovirus vectors
  • Muscle
  • Silencer
  • Tetracycline

ASJC Scopus subject areas

  • Genetics

Cite this

Salucci, V., Scarito, A., Aurisicchio, L., Lamartina, S., Nicolaus, G., Giampaoli, S., ... Palombo, F. (2002). Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system. Gene Therapy, 9(21), 1415-1421. https://doi.org/10.1038/sj.gt.3301813

Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system. / Salucci, V.; Scarito, A.; Aurisicchio, L.; Lamartina, S.; Nicolaus, G.; Giampaoli, S.; Gonzalez-Paz, O.; Toniatti, C.; Bujard, H.; Hillen, W.; Ciliberto, G.; Palombo, F.

In: Gene Therapy, Vol. 9, No. 21, 11.2002, p. 1415-1421.

Research output: Contribution to journalArticle

Salucci, V, Scarito, A, Aurisicchio, L, Lamartina, S, Nicolaus, G, Giampaoli, S, Gonzalez-Paz, O, Toniatti, C, Bujard, H, Hillen, W, Ciliberto, G & Palombo, F 2002, 'Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system', Gene Therapy, vol. 9, no. 21, pp. 1415-1421. https://doi.org/10.1038/sj.gt.3301813
Salucci, V. ; Scarito, A. ; Aurisicchio, L. ; Lamartina, S. ; Nicolaus, G. ; Giampaoli, S. ; Gonzalez-Paz, O. ; Toniatti, C. ; Bujard, H. ; Hillen, W. ; Ciliberto, G. ; Palombo, F. / Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system. In: Gene Therapy. 2002 ; Vol. 9, No. 21. pp. 1415-1421.
@article{f3122fd30e6e465dbcd7a81e3b2ea705,
title = "Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system",
abstract = "Control of gene expression for gene therapy application requires the design of a sophisticated system embodying multiple properties. The ideal system should present the following features: (1) low or undetectable gene expression in the absence of inducer; (2) strong expression upon induction; and (3) fast kinetics of induction in the presence of inducers and rapid reversal of induction after its withdrawal. To evaluate these parameters, the features of the latest generation tetracycline-sensitive reverse-transactivator (rtTA2s-M2) alone or in combination with Tet-repressor (tTS-Kid) were explored in the context of helper-dependent adenovirus vector. Various genetic elements were assembled in a series of vectors and the ability to control secreted alkaline phosphatase expression evaluated in vitro in HeLa cells and in vivo by intramuscular injection in both C57/B6 and Balb/C nude mice. The results allow us to draw some general conclusions about the combination of transcription regulators and their relative orientation to the transgene to achieve maximal induction, while minimizing leakiness of expression.",
keywords = "Gene regulation, Helper-dependent adenovirus vectors, Muscle, Silencer, Tetracycline",
author = "V. Salucci and A. Scarito and L. Aurisicchio and S. Lamartina and G. Nicolaus and S. Giampaoli and O. Gonzalez-Paz and C. Toniatti and H. Bujard and W. Hillen and G. Ciliberto and F. Palombo",
year = "2002",
month = "11",
doi = "10.1038/sj.gt.3301813",
language = "English",
volume = "9",
pages = "1415--1421",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "21",

}

TY - JOUR

T1 - Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system

AU - Salucci, V.

AU - Scarito, A.

AU - Aurisicchio, L.

AU - Lamartina, S.

AU - Nicolaus, G.

AU - Giampaoli, S.

AU - Gonzalez-Paz, O.

AU - Toniatti, C.

AU - Bujard, H.

AU - Hillen, W.

AU - Ciliberto, G.

AU - Palombo, F.

PY - 2002/11

Y1 - 2002/11

N2 - Control of gene expression for gene therapy application requires the design of a sophisticated system embodying multiple properties. The ideal system should present the following features: (1) low or undetectable gene expression in the absence of inducer; (2) strong expression upon induction; and (3) fast kinetics of induction in the presence of inducers and rapid reversal of induction after its withdrawal. To evaluate these parameters, the features of the latest generation tetracycline-sensitive reverse-transactivator (rtTA2s-M2) alone or in combination with Tet-repressor (tTS-Kid) were explored in the context of helper-dependent adenovirus vector. Various genetic elements were assembled in a series of vectors and the ability to control secreted alkaline phosphatase expression evaluated in vitro in HeLa cells and in vivo by intramuscular injection in both C57/B6 and Balb/C nude mice. The results allow us to draw some general conclusions about the combination of transcription regulators and their relative orientation to the transgene to achieve maximal induction, while minimizing leakiness of expression.

AB - Control of gene expression for gene therapy application requires the design of a sophisticated system embodying multiple properties. The ideal system should present the following features: (1) low or undetectable gene expression in the absence of inducer; (2) strong expression upon induction; and (3) fast kinetics of induction in the presence of inducers and rapid reversal of induction after its withdrawal. To evaluate these parameters, the features of the latest generation tetracycline-sensitive reverse-transactivator (rtTA2s-M2) alone or in combination with Tet-repressor (tTS-Kid) were explored in the context of helper-dependent adenovirus vector. Various genetic elements were assembled in a series of vectors and the ability to control secreted alkaline phosphatase expression evaluated in vitro in HeLa cells and in vivo by intramuscular injection in both C57/B6 and Balb/C nude mice. The results allow us to draw some general conclusions about the combination of transcription regulators and their relative orientation to the transgene to achieve maximal induction, while minimizing leakiness of expression.

KW - Gene regulation

KW - Helper-dependent adenovirus vectors

KW - Muscle

KW - Silencer

KW - Tetracycline

UR - http://www.scopus.com/inward/record.url?scp=0036846578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036846578&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3301813

DO - 10.1038/sj.gt.3301813

M3 - Article

C2 - 12378403

AN - SCOPUS:0036846578

VL - 9

SP - 1415

EP - 1421

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 21

ER -